ProtoKinetix Partners with OTC Financial Network to Increase Shareholder Base



    VANCOUVER, Canada, Oct. 14 /CNW/ -- ProtoKinetix (OTC Bulletin Board:  
PKTX), a biotech company focused on the research, development and
commercialization of patented anti-aging glycopeptides (AAGPs(TM)), announced
today that it has partnered with OTC Financial Network (OTCFN), a division of
National Financial Communications Corp. (NFC), to direct a comprehensive
shareholder awareness campaign.
    "ProtoKinetix' AAGP(TM) platform technology is ideal for a number of
applications in the skin care/cosmetics, cellular therapy, blood preservation
and pharmaceutical industries," said Geoffrey Eiten, president of NFC. "Last
month, ProtoKinetix entered into its first licensing agreement to provide
AAGP(TM) as the primary active ingredient in an anti-inflammatory cream for
the sports injury market. This contract is one of several in the pipeline that
position ProtoKinetix on a path to commercial success. We look forward to
introducing the Company and its world-class management team to the financial
community."
    "We've selected to partner with OTCFN to increase our market awareness
and widen our shareholder base," said Ross L. Senior, President and CEO of
ProtoKinetix Inc. "We are excited to be working with a financial
communications firm that has a well respected track record. We believe we can
effectively enhance shareholder value by partnering with companies that offer
the technical, marketing and distribution expertise to bring AAGP(TM)
applications to market."
    
    About OTC Financial Network
    
    Since 1992, OTC Financial Network (OTCFN) has carved its niche as the
nation's leading small/micro-cap investor relations and financial
communications firm. OTCFN is a division of National Financial Communications
Corp. (http://www.nationalfc.com) based in Needham, MA. For information, visit
http://www.otcfn.com.
    OTC Financial Network serves as special advisor to ProtoKinetix Inc. and
has received fees for services, including two hundred and fifty-thousand
shares of restricted stock, in addition to an option to purchase two-hundred
fifty-thousand shares at an exercise price of twenty cents per share, for the
creation and implementation of an awareness program. This is not an offer to
buy or sell securities. Information or opinions in this release are presented
solely for informative purposes, and are not intended nor should they be
construed as investment advice. A full disclaimer can be found online by
visiting http://www.otcfn.com/pktx/disclaimer.html.
    
    About ProtoKinetix
    
    ProtoKinetix, Inc. is a biotechnology company that has developed and
patented a family of synthetic anti-aging glycopeptides (AAGP(TM)) for
medicine and the biotechnology and cosmetic industries. PKTX is currently in
dialog with major corporations and institutions who have contacted the Company
about the broad range of applications for AAGP(TM) products. For more
information, visit http://www.protokinetix.com.
    The Private Securities Litigation Reform Act of 1995 provides a "safe
harbor" for forward-looking statements. Some information included in this
press release contains statements that are forward-looking. Such
forward-looking information involves significant risks and uncertainties that
could affect anticipated results in the future and, accordingly, these results
may differ materially from those expressed in any forward-looking statements
made by or on behalf of the Company. For a description of additional risks and
uncertainties, please refer to the Company's filings with the Securities and
Exchange Commission.

    
    CONTACT
    Ross L. Senior, LLB  -   President and CEO
    

    
    Company Office:                              Investor Contact:
    

    
    Suite # 1500                                 ProtoKinetix Inc.
    885 West Georgia Street                      604-687-9887
    Vancouver, BC V6C 3E8
    

    
    At OTC Financial Network:
    Rick McCaffrey
    781-444-6100x625
    rick@otcfn.com
    www.otcfn.com/pktx

    




For further information:

For further information: Investors, ProtoKinetix Inc., +1-604-687-9887;
or Rick McCaffrey of the OTC Financial Network, +1-781-444-6100, ext. 625,
rick@otcfn.com Web Site: http://www.protokinetix.com                
http://www.nationalfc.com                 http://www.otcfn.com

Organization Profile

PROTOKINETIX, INC.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890